[Brainlife] Newsletter, Vol.2, No.23, 24 Nov 2003

top

BRAINLIFE NEWSLETTER

Volume 2, Number 23 - 24 November 2003	Volume 2 Archive


Contents

	Etiology & Pathogenesis
	Integrative Medicine
	Prognosis & Outcome
	Treatment


Etiology & Pathogenesis

	Kenji Tada, Masato Kochi, Hideyuki Saya, Jun-Ichi Kuratsu, Shoji Shiraishi, Takanori Kamiryo, Naoki Shinojima, Yukitaka Ushio Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1 Neuro-Oncology, Volume 5, Number 4, Pages 228 -- 234 - October 2003

Integrative Medicine

	Cordes N, Plasswilm L, Bamberg M, Rodemann HP Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation Int J Radiat Biol. 2002 Jan;78(1):17-27
	Tedeschi-Blok N, Schwartzbaum J, Lee M, Miike R, Wrensch M; San Francisco Bay Area Adult Glioma Study Dietary calcium consumption and astrocytic glioma: the San Francisco Bay Area Adult Glioma Study, 1991-1995 Nutr Cancer. 2001;39(2):196-203.

Prognosis & Outcome

	Yasushi Ino, M.D., Magdalena C. Zlatescu, M.D., Hikaru Sasaki, M.D., Ph.D., David R. Macdonald, M.D., Anat O. Stemmer-Rachamimov, M.D., Sarah Jhung, B.S., David A. Ramsay, M.D., Andreas Von Deimling, M.D., David N. Louis, M.D., And J. Gregory Cairncross, M.D. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss J Neurosurg., 92:983–990, June 2000

Treatment

	Laura K. Aguilar, Estuardo Aguilar-Cordova Evolution of a Gene Therapy Clinical Trial Journal of Neuro-Oncology, 65 (3): 307-315, December 2003
	Michael A. Badruddoja, Hendrikus G. J. Krouwer, Scott D. Rand, Kelly J. Rebro, Arvind P. Pathak, Kathleen M. Schmainda Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps Neuro-Oncology, Volume 5, Number 4, Pages 235 -- 243 (October 2003)
	Isabelle M. Germano, Jennifer Fable, S. Humayun Gultekin, Adam Silvers Adenovirus/Herpes Simplex-Thymidine Kinase/Ganciclovir Complex: Preliminary Results of a Phase I trial in Patients with Recurrent Malignant Gliomas Journal of Neuro-Oncology, 65 (3): 279-289, December 2003
	Iwadate Y, Fujimoto S, Namba H, Yamaura A Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing Br J Cancer. 2003 Nov 17;89(10):1896-900
	A.H. Jacobs, J. Voges, L.W. Kracht, C. Dittmar, A. Winkeler, A. Thomas, K. Wienhard, K. Herholz, W.D. Heiss Imaging in Gene Therapy of Patients with Glioma Journal of Neuro-Oncology, 65 (3): 291-305, December 2003
	Shinji Kawabata, Shin-Ichi Miyatake, Yoshinaga Kajimoto, Yuzo Kuroda, Toshihiko Kuroiwa, Yoshio Imahori, Mitsunori Kirihata, Yoshinori Sakurai, Tohru Kobayashi, Koji Ono The Early Successful Treatment of Glioblastoma Patients with Modified boron Neutron Capture Therapy Journal of Neuro-Oncology, 65 (2): 159-165, November 2003
	Douglas Kondziolka, M.D.; Narendra Nathoo, M.D.; John C. Flickinger, M.D.; Ajay Niranjan, M.Ch.; Ann H. Maitz, M.S.; L. Dade Lunsford, M.D. Long-termResults after Radiosurgery for Benign Intracranial Tumors Neurosurgery, October 2003, Volume 53, Number 4
	Terry Lichtor, Roberta P. Glick Cytokine Immuno-Gene Therapy for Treatment of Brain Tumors Journal of Neuro-Oncology, 65 (3): 247-259, December 2003
	Magrassi L, Finocchiaro G, Milanesi G, Benvenuto F, Spadari S, Focher F Lack of enantioselectivity of herpes virus thymidine kinase allows safer imaging of gene delivery Gene Ther. 2003 Dec;10(25):2052-8
	Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration J Neurosurg. 2000 Feb;92(2):249-54
	Michael D. Prados, Michael McDermott, Susan M. Chang, Charles B. Wilson, James Fick, Kenneth W. Culver, John Van Gilder, G. Evren Keles, Alex Spence, Mitchel Berger Treatment of Progressive or Recurrent Glioblastoma Multiforme in Adults with Herpes Simplex Virus Thymidine Kinase Gene Vector-Producer Cells Followed by Intravenous Ganciclovir Administration: A Phase I/II Multi-Institutional Trial Journal of Neuro-Oncology, 65 (3): 269-278, December 2003
	Nikolai G. Rainov, Huan Ren Clinical Trials with Retrovirus Mediated Gene Therapy – what Have we Learned? Journal of Neuro-Oncology, 65 (3): 227-236, December 2003
	H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy British Journal of Cancer, 3 November 2003, Volume 89, Number 9, 1605-1609
	J.H. Sampson ; G. Akabani ; G.E. Archer ; D.D. Bigner ; M.S. Berger ; A.H. Friedman ; H.S. Friedman ; J.E. Herndon II ; S. Kunwar ; S. Marcus ; R.E. McLendon ; A. Paolino ; K. Penne ; J. Provenzale ; J. Quinn ; D.A. Reardon ; J. Rich ; T. Stenzel ; S. Tourt-Uhlig ; C. Wikstrand ; T. Wong ; R. Williams ; F. Yuan ; M.R. Zalutsky ; I. Pastan Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors Journal of Neuro-Oncology, October 2003, Volume 65, Number, 1, Pages 27 – 35
	Amish C. Shah, Dale Benos, G. Yancey Gillespie, James M. Markert Oncolytic Viruses: Clinical Applications as Vectors for the Treatment of Malignant Gliomas Journal of Neuro-Oncology, 65 (3): 203-226, December 2003
	Giacomo G. Vecil, Frederick F. Lang Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses Journal of Neuro-Oncology, 65 (3): 237-246, December 2003
	Jun Yoshida, Masaaki Mizuno Clinical Gene Therapy for Brain Tumors. Liposomal Delivery of Anticancer Molecule to Glioma Journal of Neuro-Oncology, 65 (3): 261-267, December 2003

bottom